Purchases and Sales Made in Q1 2025 in Amylyx Pharmaceuticals, Inc. (AMLX)
This table provides information about the institutional ownership of Amylyx Pharmaceuticals, Inc. (AMLX) during Q1 2025. The information is specifically focused on institutions that hold shares of Amylyx Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2025
Q1 2025
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-46.7K- 44.0% |
$140K - $194K
|
59.5K
$375K
|
|
|
May 12, 2025
Q1 2025
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-63.7K- 5.04% |
$191K - $264K
|
1.2M
$7.56M
|
|
|
May 15, 2025
Q1 2025
|
Alyeska Investment Group, L.P.
Chicago, IL |
SELL
|
- |
-73K- 8.87% |
$219K - $303K
|
750K
$4.73M
|
|
|
May 15, 2025
Q1 2025
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-76.8K- 39.6% |
$230K - $319K
|
117K
$738K
|
|
|
May 12, 2025
Q1 2025
|
Citigroup Inc
|
SELL
|
- |
-146K- 23.97% |
$438K - $606K
|
463K
$2.92M
|
|
|
May 15, 2025
Q1 2025
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-238K- 75.52% |
$714K - $987K
|
77.1K
$486K
|
|
|
May 14, 2025
Q1 2025
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-268K- 51.64% |
$804K - $1.11M
|
251K
$1.58M
|
|
|
May 21, 2025
Q1 2025
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-370K- 60.44% |
$1.11M - $1.53M
|
242K
$1.53M
|
|
|
May 15, 2025
Q1 2025
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-389K- 82.4% |
$1.17M - $1.62M
|
83.1K
$524K
|
|
|
May 14, 2025
Q1 2025
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-434K- 56.73% |
$1.3M - $1.8M
|
331K
$2.09M
|
|
|
May 15, 2025
Q1 2025
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-1.63M- 67.26% |
$4.9M - $6.77M
|
794K
$5M
|